Monotherapy in patients with type 2 diabetes mellitus

Citations

WEB OF SCIENCE

5
Citations

SCOPUS

6

초록

In order to improve the quality of life and to prevent chronic complications related to diabetes mellitus, intensive lifestyle modification and proper medication are needed from the early stage of diagnosis of type 2 diabetes mellitus (T2DM). When using the first medication for diabetic patients, the appropriate treatment should be selected considering the clinical characteristics of the patient, efficacy of the drug, side effects, and cost. In general, the use of metformin as the first treatment for oral hypoglycemic monotherapy is recommended because of its excellent blood glu-cose-lowering effect, relatively low side effects, long-term proven safety, low risk of hypoglycemia, and low weight gain. If metformin is difficult to use as a first-line treatment, other appropriate medications should be selected in view of the clinical situation. If the goal of achieving glycemic control is not achieved by monotherapy, a combination therapy with different mechanisms of action should be initiated promptly.

키워드

Diabetes mellitus, type 2; Hypoglycemic agents; Metformin; Practice guideline; DIPEPTIDYL PEPTIDASE-4 INHIBITORS; GLUCOSE-LOWERING EFFICACY; LONG-TERM METFORMIN; BLOOD-GLUCOSE; CARDIOVASCULAR OUTCOMES; PREVENTION PROGRAM; GLYCEMIC CONTROL; LIFE-STYLE; METAANALYSIS; EVENTS
제목
Monotherapy in patients with type 2 diabetes mellitus
저자
Rhee, Sang Youl; Kim, Hyun Jin; Ko, Seung-Hyun; Hur, Kyu Yeon; Kim, Nan-Hee; Moon, Min Kyong; Park, Seok-O; Lee, Byung-Wan; Choi, Kyung Mook; Kim, Jin Hwa
DOI
10.3904/kjim.2017.312
발행일
2017-11
유형
Review
저널명
The Korean Journal of Internal Medicine
권
32
호
6
페이지
959 ~ 966